Medicines Formulary

Reports

Status	Drug name	NICE TAs	Comments
	Measles, Mumps and Rubella vaccine, live (MMR)		Supported with PGD
	Mebeverine tablets 135mg
	Medroxyprogesterone acetate (Sayana Press) 104mg in 0.65ml SC injection		Suitable for self-injection in patients who have had appropriate training
	Medroxyprogesterone acetate tablets		Provera and Climanor
	Mefenamic acid capsules		For dysmenorrhoea
	Mefenamic acid tablets		For dysmenorrhoea
	Menadiol sodium phosphate tablets
	Meningiococcal A, C W135, and Y conjugate vaccine (Menveo®)		For use in patients visiting Saudi Arabia for Hajj and other high risk destinations. Likely to be more long lasting than the alternative polysaccharide vaccine. Supported with PGD.
	Meningiococcal group C conjugate vaccine (Menjugate Kit®, Neis Vac-C®)		Supported with PGD
	Meningococcal group B vaccine (Bexsero®)

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
Next page
Last page

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.